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Urinary complications are common following renal
transplantation. The aim of this study is to evaluate the
risk factors associated with renal transplant urinary
complications. We collected data on 1698 consecutive
renal transplants patients. The association of donor,
transplant and recipient characteristics with urinary
complications was assessed by univariable and multi-
variable Cox proportional hazards models, fitted to an-
alyze time-to-event outcomes of urinary complications
and graft failure. Urinary complications were observed
in 105 (6.2%) recipients, with a 2.8% ureteral stricture
rate, a 1.7% rate of leak and stricture, and a 1.6% rate
of urine leaks. Seventy percent of these complications
were definitively managed with a percutaneous inter-
vention. Independent risk factors for a urinary com-
plication included: male recipient, African American
recipient, and the “U”-stitch technique. Ureteral stric-
ture was an independent risk factor for graft loss, while
urinary leak was not. Laparoscopic donor technique
(compared to open living donor nephrectomy) was not
associated with more urinary complications. Our data
suggest that several patient characteristics are asso-
ciated with an increased risk of a urinary complica-
tion. The U-stitch technique should not be used for the
ureteral anastomosis.
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Introduction
It is well established that urinary complications are associ-
ated with significant morbidity following the kidney trans-
plant operation (1–13). The literature on urinary complica-
tions following kidney transplant is limited to numerous,
relatively small single center experiences and these stud-
ies are too small to provide risk factor analysis for urinary
complications. A comprehensive evaluation of posttrans-
plant urinary complications, focusing on risk factors, man-
agement and the effects on graft function, will enable the
clinician to better inform and manage patients.
In this series, we review our experience with urinary com-
plications in renal transplantation. We report 105 urinary
complications in 1698 consecutive renal transplants. This
large number of cases allows us to complete a multivari-
able analysis to assess the risk factors for urinary complica-
tions in various subgroups of patients. In addition, we as-
sess the effects of urinary complications on graft function.
Based on our findings, we conclude with clinical recom-




Electronic medical records for all recipients of renal transplants performed
consecutively between 7/1/1995 and 7/1/2004 (n = 1698) at the University
of Michigan Health System were retrospectively evaluated. Patients who
received simultaneous kidney-pancreas, kidney-liver, kidney-heart trans-
plants, or did not have a ureteral anastomosis to the bladder were excluded.
Data regarding donor, transplant, surgeon (n = 9), and recipient charac-
teristics as well as graft and patient outcomes were obtained from both
a prospectively collected database and review of the electronic medical
record and from a dataset provided by the Scientific Registry of Transplant
Recipients, based on data submitted by our center to the Organ Procure-
ment and Transplantation Network. Urinary complications were identified
by review of radiographic, laboratory and operative records. All bladder
anastomoses were completed as a Lich-Gregoir (external ureteroneocys-
tostomy) or using the single U-stitch technique (utilized by a single sur-
geon) Briefly, the Lich-Gregoir is a continuous suture around the spatu-
lated circumference of the ureter and cystotomy mucosal layer, with clo-
sure of the bladder muscle layer over the anastomosis to prevent reflux
(14). The U-stitch technique entails tacking the hood of the ureter to the
inside wall of the bladder with a single “U” stitch. The myotomy is then
closed over the ureter creating an antirefluxing tunnel (15–17). Data on op-
eratively placed stents were available from 1/1/2001 to 7/1/2004. Internal
double-J ureteral stents were selectively placed per surgeon preference
and transurethral catheters were left in place for 48 h. Patients were man-
aged with three agent maintenance immunosuppression in the immediate
postoperative period (cyclosporine, corticosteroids and an antimetabolite).
Sirolimus was not used for initial immunosuppression. Immunologically high
risk recipients (PRA > 30, African American, or previous transplant) received
polyclonal antithymocyte globulin.
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Risk factors
Risk factors evaluated as possible predictors of urinary complications in-
cluded era of transplant, sex, age, race, comorbidities, etiology of renal fail-
ure, history of previous renal transplant, donor characteristics, ureteroneo-
cystostomy technique, surgeon, rejection and ischemia times. Expanded
criteria donor (ECD) were classified according to Port et al. and included all
donors greater than or equal to 60 years of age, plus those donors between
50 and 59 years with at least two of the following three factors: serum cre-
atinine greater than 1.5 mg/dL, cerebrovascular accident as cause of death,
and history of hypertension (18). Data regarding rejection episodes were
limited to the first post-operative year.
Definition of urinary complication
For the purposes of this study, urinary complications were defined as symp-
tomatic urinary leak or ureteral stricture requiring intervention. In the Cox
model for graft failure, patients with both a urinary leak and stricture were
categorized as having a urinary leak.
Human subjects protection
The study was approved by the University of Michigan Institutional Review
Board prior to data collection and analysis.
Statistical analysis
The association of donor, transplant and recipient characteristics with uri-
nary complications was assessed by univariable and multivariable Cox pro-
portional hazards models, fitted to analyze time-to-event outcomes of uri-
nary complications and graft failure. All statistical analyses were performed
using SAS version 9.1.
Results
Patient characteristics
The baseline characteristics of the study population (1698
consecutive renal transplants) are detailed in Table 1. The
mean posttransplant follow-up was 1446 ± 962 days. Male
recipients predominated (58%), and 79% of recipients
were white. Diabetes was the most common etiology of
renal failure in the study group. Fifty-six percent of the kid-
neys were from living donors and approximately 40% of
the living donor transplants were procured via a laparo-
scopic approach.
Urinary complication incidence and management
There were 105 (6.2%) urinary complications observed dur-
ing follow-up (Table 2). Two complications were from blood
clots after biopsy and one was from a stone (excluded
from analysis). The overall urinary complication rates for
living donor and deceased donor transplants were 5.7%
and 7.8%, respectively.
Isolated ureteral stricture without leak occurred in 47 cases
(2.8%) and was the most common urinary complication,
representing 44.7% of all urinary complications. More than
two-thirds (68.1%) of strictures were managed nonopera-
tively with a percutaneously placed nephroureteral stent
with or without balloon ureteroplasty. The remaining 15
patients required operative reconstruction.












African American 245 14.4
Hispanic 27 1.6
Other 84 4.9
Etiology of renal failure
Diabetes mellitus 448 26.4
Glomerulonephritis 300 17.7
Hypertension 227 13.4
Polycystic kidney disease 149 8.8







Living related 704 41.5




Ureteral stricture with associated urine leak occurred in
28 cases (1.7%), representing 26.7% of urinary complica-
tions. Of these, 21 (75.0%) were managed with a percuta-
neous nephrostomy tube or nephroureteral stent, with or
without balloon ureteroplasty, while the remainder (n = 7)
required an operative reconstruction.
Urine leaks occurred in 27 cases (1.6%) and represented
25.7% of the ureteral complications. Three patients with
obvious urine leaks in the immediate postoperative period
were taken directly to the operating room. The remain-
der of the patients had initial placement of a percutaneous
nephroureteral stent. If an internal stent had been placed
at the time of the operation, it was removed at the time
of the nephroureteral stent placement. Eighteen (66.6%)
of the urine leaks were ultimately managed either with a
Table 2: Incidence of urinary complications and percent
amenable to nonoperative management (n = 1698)
Percent of Percent managed
Complication N transplants without reoperation
Stricture 47 2.77 68.1
Leak and stricture 28 1.65 75.0
Leak 27 1.59 66.6
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Table 3: Univariable Cox regression analysis of risk factors for the development of a urinary complication following renal transplantation
HR 95% Lower 95% Upper p-Value
“U” stitch technique 1.99 1.66 2.32 0.04
Male recipient 1.87 1.65 2.08 0.004
African American recipient 1.88 1.66 2.11 0.005
ECD donor∗ 2.09 1.74 2.45 0.04
Lap nephrectomy (compare to DD)∗∗ 0.58 0.21 1.00 0.052
Open nephrectomy (compare to DD)∗∗ 0.83 0.62 1.05 0.829
Nondiabetic recipient 1.50 1.25 1.75 0.10
Female donor 1.47 0.95 1.94 0.08
Previous transplant 1.30 0.59 2.28 0.38
Recipient age (per 10 years) 1.10 0.90 1.20 0.86
Donor age (per 10 years) 0.90 0.80 1.00 0.13
Recipient BMI (per 5 kg/m2) 0.95 0.85 1.1 0.68
∗ ECD donor = expanded criteria kidney donor.
∗∗ Compared to deceased donor renal transplant.
percutaneous nephrostomy tube with nephroureteral stent
while the remainder of the urine leaks required an operative
reconstruction.
All of the urine leaks, with or without strictures, presented
within 100 days of the renal transplant (median time from
renal transplant to presentation with a urine leak was 11.5
days (interquartile range [IQR] 8, 24.5)). Interestingly, 16
(34.0 %) of the ureteral strictures without leaks presented
greater than 100 days following the transplant (median
time from renal transplant to presentation with a stricture
was 19 days (IQR 8,69)).
Overall, 73 (69.5%) of the urinary complications were man-
aged percutaneously without operative reconstruction.
Risk factors for urinary complications
Factors significantly associated with urinary complication
in univariable analysis included U-stitch technique, male re-
cipient, African American recipient, ECD kidney, and laparo-
scopic donor nephrectomy (compared to deceased donor
renal transplants). (Table 3) Urinary complications were not
associated with previous transplant, warm ischemia time,
cold ischemia time, surgeon identifier, total ischemia time,
donor or recipient body mass index (BMI), episode of acute
rejection or donor or recipient age.
A multivariable Cox proportional hazards regression model
(adjusted for U-stitch, recipient sex, recipient race, recip-
ient diabetes and technique of organ procurement (la-
paroscopic living donor nephrectomy, open living donor
nephrectomy or deceased donor) was fitted to define inde-
pendent risk factors for a urinary complication (Table 4). We
found that U-stitch technique, male recipients, and African
American recipients were all associated with a higher risk
of a urinary complication.
Placement of an intraoperative ureteral stent was com-
monly done (30.4% of all transplants done between
1/1/2001 and 7/1/2004 (n = 681). Of patients who did not
have a stent placed, 5.7% had urinary complications, com-
pared to 4.3% in patients who had a stent placed at the
time of transplant. This difference was not statistically sig-
nificant. Patients with an internal stent and complications
presented with urinary leaks. The complication rate directly
related to the stent was difficult to assess, but obstruction
thought related to the stent occurred in only one patient
and the stent was removed earlier than initially planned
(6–8 weeks) in 1.8% of patients due to persistent urinary
tract infections.
A multivariable Cox proportional hazards regression model
(adjusted for year of transplant, ureteral stricture, ureteral
leak, recipient diabetes, recipient race, recipient sex and
technique of organ procurement) was completed to iden-
tify independent risk factors for graft loss. This model
noted that ureteral stricture (but not ureteral leak), recip-
ient diabetes, African American recipient, and deceased
donor nephrectomy (compared to laparoscopic living donor
nephrectomy and open living donor nephrectomy) were all
independently associated with graft loss (Table 5).
Figure 1 notes the adjusted rates of urinary complications
among African American and non-African American males
and females.
Discussion
We have shown that recipient factors of male sex, African
American race and the U-stitch anastomotic technique, are
each significant and independent risk factors for urinary
complications after renal transplantation. These findings
may be useful to better inform patients about the risks of
complications and to assist surgeons in making decisions
about management of the urinary reconstruction.
Some interesting insights into the pathophysiology of uri-
nary complications can be gained from our results. Urine
leak is presumably related to technical issues (either with
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Table 4: Risk factors for development of a urinary complication from a Cox proportional hazards regression model
HR 95% Lower 95% Upper p-Value
‘U’ stitch technique 1.95 1.59 2.27 0.045
Male recipient 1.94 1.72 2.15 0.002
African American recipient 1.73 1.50 1.96 0.019
Non diabetic recipient 1.53 0.96 2.10 0.089
Lap nephrectomy (compare to DD)∗ 0.63 0.18 1.09 0.111
Open nephrectomy (compare to DD)∗ 0.91 0.80 1.02 0.659
∗ Compared to deceased donor renal transplants
the donor operation or the transplant itself) and, as ex-
pected, presented early. Conversely, one-third of isolated
strictures presented late (more than 100 days posttrans-
plant). These strictures frequently involved a long segment
of the donor ureter and were often located proximal to
the bladder anastomosis. In addition, ureteral stricture is
a significant risk factor for graft loss, while urinary leak
is not. Even though late strictures may be related to is-
chemia or rejection (11, 19), patients with late strictures in
our study did not have seem to have more early rejection
(data not shown). The correlation between graft loss and
ureteral stricture may be related to rejection and further
study is needed to define this relationship. Nonetheless,
these data suggest that urinary leaks and strictures can
represent different pathophysiologic processes and should
be separated in future analyses.
Among the most interesting findings in the risk factor mod-
els are that male and African American recipients had sig-
nificantly more urinary complications than female and non-
African American recipients, respectively (Figure 1). Thus,
African American males were almost four times more likely
to have a urinary complication compared to non-African
American females. It is possible that the anastomosis is
technically more difficult in males related to a deeper, nar-
rower pelvis. Along similar lines, one might posit that BMI
would be an independent risk factor for urinary complica-
tions (higher BMI being associated with a technically more
difficult operation), but this has not been the case in either
our study or the reported experience from other groups
(20, 21). There are likely many complex urodynamic fac-
Figure 1: Adjusted ureteral complication rates among 1698
consecutive renal transplants.
tors (such as bladder size and function, urinary outflow ob-
struction, length of time anuric prior to transplant) and other
clinical factors which predispose male and/or African Amer-
ican recipients to urinary complications, and further study
is warranted. There is a modest amount of data reporting
more urinary complications in pediatric boys compared to
girls (8). It is notable that we did not assess induction ther-
apy as a potential risk factor for a urinary complication, and
this may affect African American being a truly independent
risk factor for urinary complications. African American re-
cipients received polyclonal antithymocyte induction at the
time of transplant, compared to only a small subset of non-
African Americans. Further study is needed to determine if
antibody induction therapy influences urinary complication
rates.
The U-stitch anastomotic technique, which was associated
with significant risk, has not been utilized at our center for
a number of years, and we recommend against its use.
Like many centers, we now use laparoscopic (hand-
assisted) donor nephrectomy to procure approximately
95% of living donor kidneys. Contrary to other published
reports (22–24), laparoscopic donor nephrectomy was not
associated with more urinary complications, even when
controlled for the year of transplant. Actually, compared to
open living donor nephrectomy, there was a trend towards
fewer complications. This finding could be related to metic-
ulous attention to preservation of periureteral tissue. In our
group’s experience, it is easier to preserve periureteral tis-
sue when the operative field is under laparoscopic magni-
fication.
For many years, we have utilized a mainly nonoperative
approach to the management of leaks and strictures, em-
ploying percutaneous nephrostomy tube drainage and con-
version to a universal stent with balloon ureteroplasty as
needed. Our results support this practice, as the major-
ity of patients can be successfully managed without the
need for a secondary operation. Further study is needed to
characterize those patients who fail percutaneous manage-
ment of their urinary complication. Identification of risk fac-
tors for failure of the percutaneous approach would reduce
the incidence of prolonged and ultimately unsuccessful
nonoperative management. The observation that urinary
leaks were not associated with graft loss is reassuring both
to caregivers and to patients who experience a leak and
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Table 5: Risk factors for graft loss from a Cox proportional hazards regression model adjusted for year of transplant
HR 95% Lower 95% Upper p-Value
Ureteral stricture 1.69 1.45 1.93 0.033
Recipient diabetes 1.49 1.38 1.60 0.001
African American recipient 1.37 1.06 1.68 0.017
Lap nephrectomy (compare to DD)∗ 0.58 0.39 0.77 0.005
Open nephrectomy (compare to DD)∗ 0.61 0.50 0.72 0.001
Transplant year (per year forward) 0.95 0.89 1.01 0.055
Male recipient 1.08 0.98 1.19 0.473
Ureteral leak 1.16 0.90 1.41 0.630
∗ Compared to deceased donor renal transplants.
require a nephrostomy tube in the months following a kid-
ney transplant.
There are multiple case series and five randomized trials
indicating that ureteral stents reduce urinary complication
rates with minimal risk of stent-related complications (2,
4–6, 9, 10). Considering the selection bias related to de-
cision to place an intraoperative stent, it is not possible
to compare rates of ureteral complications between the
stented and nonstented patients in our cohort. In addition,
the study was not designed to inform decision making re-
garding stenting practices.
It is important to point out the limitations of this study.
Its design as a retrospective, single center cohort analy-
sis hampers our ability to ascribe direct causality to any
of the significant risk factors we have identified. In addi-
tion, despite the identification of multiple independent risk
factors for urinary complications, the mediation of their ef-
fects may be complex, unexplored interactions among the
factors may exist, and additional confounders may remain
unmeasured and therefore uncharacterized.
In summary, our series has noted several significant risk
factors for ureteral complications. We conclude that the U-
stitch technique should not be used for the ureteral anas-
tomosis. This comprehensive evaluation of posttransplant
urinary complications, focusing on risk factors, manage-
ment, and the effects on subsequent graft failure, should
enable clinicians to better inform and manage patients. Fur-
ther study is needed to attribute causality of these risk fac-
tors to higher rates of urinary complications.
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